Factors | Median OS (months), range | P value |
Age |
| 0.105 |
≤45 | 11 (10 - 13) | |
>45 | 7.5 (4 - 13) | |
Sex |
| 0.101 |
Male | 11 (4 - 13) | |
female | 8 (5 - 11) | |
ECOG performance status |
| 0.036 |
1 | 11 (6 - 13) | |
2 | 5 (4 - 12) | |
Primary surgical treatment |
| 0.626 |
Biopsy | 6 (4 - 12) | |
Subtotal excision | 10 (5 - 13) | |
Total excision | 10.5 (10 - 11) | |
Primary systemic treatment |
| 0.138 |
Temozolamide | 11.5 (6 - 13) | |
CVP | 10 (4 - 13) | |
Time interval |
| 0.407 |
≤12 month | 10 (4 - 13) | |
>12 month | 10 (6 - 13) | |
Re-irradiation volume |
| 0.691 |
≤100 cm3 | 10 (4 - 13) | |
>100 cm3 | 10 (5 - 13) |